What Does GENFIT Do?

Total employees198
HeadquartersLoos
Founded1999

Genfit is a late-stage biopharmaceutical company focused on the discovery and development of innovative therapeutic and diagnostic solutions for metabolic and liver-related diseases, particularly those with high unmet medical needs. The company's primary efforts are concentrated on conditions such as Primary Biliary Cholangitis (PBC) and other liver ailments. Genfit leverages its expertise in nuclear receptor-based drug discovery and clinical development to advance its pipeline, aiming to provide impactful treatments to patients worldwide.

Where Is GENFIT's Headquarters?

HQ Function

The Loos headquarters serves as the nerve center for Genfit's global operations, housing its primary research and development laboratories, clinical development teams, corporate administration, and strategic decision-making functions.

Notable Features:

Located within Parc Eurasanté, a leading European life sciences and healthcare innovation park, offering state-of-the-art facilities and fostering collaboration within a rich ecosystem of research institutions and biotech companies.

Work Culture:

Genfit promotes a collaborative, science-driven work culture focused on innovation and a commitment to addressing unmet medical needs in liver and metabolic diseases. The environment encourages scientific rigor, teamwork, and agility in advancing its therapeutic programs.

HQ Significance:

This site is crucial for Genfit's identity and operations, being the birthplace of its key drug candidates and the central point for coordinating its extensive global clinical trials and research collaborations.

Values Reflected in HQ: The headquarters' location and design reflect Genfit's core values of scientific excellence, innovation, collaboration (being in a biotech hub), and a patient-focused approach to drug development.

Location:

Genfit maintains a global operational footprint to support its extensive research, clinical development, and future commercialization activities. Key functions supported globally include conducting multinational clinical trials across North America, Europe, and other regions; engaging with international regulatory bodies like the FDA (USA) and EMA (Europe); fostering worldwide collaborations and partnerships for drug development and commercialization; and managing investor relations on an international scale. While its R&D and corporate hub is in France, its U.S. presence is critical for market access and clinical operations.

Street Address:

Parc Eurasanté, 885 Avenue Eugène Avinée

City:

Loos

State/Province:

Hauts-de-France

Country:

France

Where Else Does GENFIT Operate Around the World?

Cambridge, Massachusetts, USA

Address: One Broadway, 14th Floor, Cambridge, MA 02142, USA

To facilitate clinical trials in the U.S., engage with American regulatory authorities, connect with the U.S. investment community, and expand Genfit's strategic partnerships within the world's largest pharmaceutical market.

Buying Intent Signals for GENFIT

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading GENFIT? Meet the Executive Team

As of April 2025, GENFIT' leadership includes:

Pascal Prigent - Chief Executive Officer
Dean W. Hum, Ph.D. - Chief Scientific Officer & Chief Operating Officer
Stefano Rinaldi, M.D. - Chief Medical Officer
Nathalie Huitorel - Chief Financial Officer
Carol Addy, MD, MBA - Chief Business Officer

Who's Investing in GENFIT?

GENFIT has been backed by several prominent investors over the years, including:

Biotech Value Fund L.P.
Armistice Capital LLC
PointState Capital LP
Federated Hermes (various funds)
Sofinnova Partners (historical key investor)

What Leadership Changes Has GENFIT Seen Recently?

Hire1
Exits0

In the past year, Genfit strategically enhanced its leadership by appointing a new Chief Business Officer, aiming to bolster its business development and corporate strategy efforts as its lead drug candidates progress towards potential market authorization.

New Appointments:

Carol Addy, MD, MBA, Carol Addy was appointed as Chief Business Officer, bringing extensive experience in biopharma business development, corporate strategy, and alliance management to Genfit.

What Technology (Tech Stack) Is Used byGENFIT?

Discover the tools GENFIT uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

GENFIT Email Formats and Examples

Genfit's email format typically follows a standard corporate structure. The most common pattern observed is the employee's first initial combined with their full last name, or first name separated by a dot from their last name.

flastname@genfit.com or firstname.lastname@genfit.com

Format

jsmith@genfit.com or john.smith@genfit.com

Example

80%

Success rate

What's the Latest News About GENFIT?

GlobeNewswireMay 2, 2024

Genfit Reports First Quarter 2024 Financial Results and Provides Corporate Update

GENFIT reported its cash position, revenues, and operating expenses for Q1 2024, alongside updates on its key programs including elafibranor for PBC and GNS561 for cholangiocarcinoma. The company highlighted the upcoming PDUFA date for elafibranor in June 2024....more

GlobeNewswireApril 8, 2024

Genfit Announces Presentations at EASL Congress™ 2024 Highlighting its Leadership in Liver Disease

Genfit announced multiple presentations at the EASL Congress 2024, showcasing new data on elafibranor in PBC and other research in ACLF and liver diseases, reinforcing its scientific contributions to the field....more

GlobeNewswireFebruary 15, 2024

Genfit Announces Publication in the New England Journal of Medicine of Positive Results from the Phase 3 ELATIVE™ Trial Evaluating Elafibranor in Primary Biliary Cholangitis (PBC)

Genfit announced the publication of pivotal Phase 3 ELATIVE™ trial results for elafibranor in PBC in the prestigious New England Journal of Medicine, underscoring the drug's efficacy and safety profile and its potential as a new treatment option for this chronic liver disease....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including GENFIT, are just a search away.